ABAD Directly Links Aß to Mitochondrial Toxicity in Alzheimer's Disease
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Mitochondrial dysfunction is a hallmark of β-amyloid (Aβ)–induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Aβ-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Aβ to mitochondrial toxicity. Aβ interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Aβ-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Aβ interaction and suppresses Aβ-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Aβ-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Aβ interaction may be a therapeutic target in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, Aβ interacts specifically with mitochondrial Aβ-binding alcohol dehydrogenase (ABAD), impeding the binding of NAD to ABAD and inducing ROS production.287,288”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [287]
In the citing paper
“A number of studies have associated intraneuronal Ab buildup with hyperphosphorylation of tau protein, 8 disturbed protein trafficking and sorting, 9 reduced expression of synaptic proteins, 10 and mitochondrial dysfunction.11,12”
From Blocking the Interaction between Apolipoprotein E and Aβ Reduces Intraneuronal Accumulation of Aβ and Inhibits Synaptic Degeneration (2013) · cites this paper as [11]
In the citing paper
“Aβ, and its precursor APP, localize, in part, to mitochondria in which they can cause mitochondrial dysfunction as evidenced by increased production of RS, enzyme inhibition, loss of cytochrome c, and depolarization of Δψm (Casley et al., 2002a; Kim et al., 2002; Anandatheerthavarada et al., 2003; Jang and Surh, 2003; Lustbader et al., 2004; Liang et al., 2009; Takuma et al., 2009).”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Aβ is reported to increase RS in neurons via multiple mechanisms, including direct Aβ-induced RS production, elevated NADPH oxidase activity, interaction with mitochondria-associated Aβ alcohol dehydrogenase, inhibition of cytochrome oxidase (respiratory complex IV), and by causing leakage of electrons from the mitochondrial electron transport chain (Hensley et al., 1994; Canevari et al., 1999; L”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
In the citing paper
“Intracellular Aβ may then enter the mitochondria in which it induces additional RS and magnifies the metabolic deficit”
From The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease (2011) · cites this paper as Lustbader et al., 2004
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Treatment of Ischemic Brain Damage by Perturbing NMDA Receptor- PSD-95 Protein Interactions
Aarts, M., Liu, Y., Liu, L., Besshoh, S., Arundine, M., Gurd, J. W., Wang, Y.-T., Salter, M. W., & Tymianski, M. (2002) · Science · doi:10.1126/science.1072873 · Cited by 999
Rego, A. C., & Oliveira, C. R. (2003) · Neurochemical Research · doi:10.1023/a:1025682611389 · Cited by 472
TAT-Mediated Protein Transduction into Mammalian Cells
Becker-Hapak, M., McAllister, S. S., & Dowdy, S. F. (2001) · Methods · doi:10.1006/meth.2001.1186 · Cited by 384
Du Yan, S., Fu, J., Soto, C., Chen, X., Zhu, H., Al-Mohanna, F., Collison, K., Zhu, A., Stern, E., Saido, T., et al. (1997) · Nature · doi:10.1038/39522 · Cited by 379
Self-citationRole of mitochondrial dysfunction in Alzheimer's disease
Castellani, R., Hirai, K., Aliev, G., Drew, K. L., Nunomura, A., Takeda, A., Cash, A. D., Obrenovich, M. E., Perry, G., & Smith, M. A. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10389 · Cited by 364
Mitochondria in Alzheimer's disease
Swerdlow, R. H., & Kish, S. J. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)53013-0 · Cited by 126
Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity
Du Yan, S., Shi, Y., Zhu, A., Fu, J., Zhu, H., Zhu, Y., Gibson, L., Stern, E., Collison, K., Al-Mohanna, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2145 · Cited by 120
Self-citationGrill, H. P., Zweier, J. L., Kuppusamy, P., Weisfeldt, M. L., & Flaherty, J. T. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90457-x · Cited by 108
Self-citation
Research works printed but not linked: 2
- M. A. Abreoet al. U.S. Patent and Trademark Office serial number 931186 (2002) vol. 9.
- We thank D. Eliezer and T. McGraw for helpful discussions K. D'Amico and L. Tong for help with data collection at the Advanced Photon Source and D. Landry for help with the surface plasmon resonance experiment. This work was supported by P50AG08702 AG16736 AG17490 and NS42855 and in part by Speaker's Fund for Biomedical Research and NIH 1K07AG00959. H.W. is a Pew Scholar of biomedical sciences and a Rita Allen Scholar. The atomic coordinates have been deposited in the Protein Data Bank (PDB accession code 1SO8).
Cited by
Items 401–500 of 1,002
Lipid metabolism and neuroinflammation in Alzheimer’s disease: a role for liver X receptors
Kang, J., & Rivest, S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1049 · Cited by 94
Karvandi, M. S., Hesari, F. S., Aref, A. R., & Mahdavi, M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1105247 · Cited by 114
Amyloid-β Triggers the Release of Neuronal Hexokinase 1 from Mitochondria
Saraiva, L. M., Seixas da Silva, G. S., Galina, A., da-Silva, W. S., Klein, W. L., Ferreira, S. T., & De Felice, F. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015230 · Cited by 94
Amadoro, G., Corsetti, V., Atlante, A., Florenzano, F., Capsoni, S., Bussani, R., Mercanti, D., & Calissano, P. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.08.001 · Cited by 103
Atlante, A., Amadoro, G., Bobba, A., Lidia de, B. A. R. I., Corsetti, V., Pappalardo, G., Marra, E., Calissano, P., & Passarella, S. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.07.004 · Cited by 103
Amyloid-β Peptide Binds to Cytochrome C Oxidase Subunit 1
Hernandez-Zimbron, L. F., Luna-Muñoz, J., Mena, R., Vazquez-Ramirez, R., Kubli-Garfias, C., Cribbs, D. H., Manoutcharian, K., & Gevorkian, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042344 · Cited by 92
Oxidative damage as an early marker of Alzheimer's disease and mild cognitive impairment
Beal, M. F. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.09.022 · Cited by 98
Mitochondrial Dysfunction in Neurodegenerative Diseases
Yang, H. (2025) · Cells · doi:10.3390/cells14040276 · Cited by 103
Shih, Y.-H., Tu, L.-H., Chang, T.-Y., Ganesan, K., Chang, W.-W., Chang, P.-S., Fang, Y.-S., Lin, Y.-T., Jin, L.-W., & Chen, Y.-R. (2020) · Nature Communications · doi:10.1038/s41467-020-19786-7 · Cited by 91
Moreira, P. I., Santos, M. S., Sena, C. M., NUNES, E., Seiça, R. M. F., & Oliveira, C. R. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.07.012 · Cited by 97
Direct evidence for coherent low velocity axonal transport of mitochondria
Miller, K. E., & Sheetz, M. P. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200510097 · Cited by 91
Proteomic research in psychiatry
Taurines, R., Dudley, E., Grassl, J., Warnke, A., Gerlach, M., Coogan, A. N., & Thome, J. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109106931 · Cited by 92
Synaptosomal Mitochondrial Dysfunction in 5xFAD Mouse Model of Alzheimer's Disease
Wang, L., Guo, L., Lu, L., Sun, H., Shao, M., Beck, S. J., Li, L., Ramachandran, J., Du, Y., & Du, H. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150441 · Cited by 93
Kuszczyk, M. A., Sanchez, S., Pankiewicz, J., Kim, J., Duszczyk, M., Guridi, M., Asuni, A. A., Sullivan, P. M., Holtzman, D. M., & Sadowski, M. J. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.01.034 · Cited by 97
Park, S.-S., Park, H.-S., Kim, C., Kang, H., Kim, D., Baek, S., & Kim, T.-W. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00631-4 · Cited by 97
Tan, J. W., & Kim, M. (2016) · Molecules · doi:10.3390/molecules21050548 · Cited by 98
ets-2 Promotes the Activation of a Mitochondrial Death Pathway in Down's Syndrome Neurons
Helguera, P., Pelsman, A., Pigino, G., Wolvetang, E., Head, E., & Busciglio, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5107-04.2005 · Cited by 88
The synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degeneration
Борисович, Б. И., & Hiesinger, P. R. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-23 · Cited by 92
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.01.008 · Cited by 85
Liu, Y., Li, H., Wang, J., Xue, Q., Yang, X., Kang, Y., Li, M., Xu, J., Li, G., Li, C., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.18777 · Cited by 93
New insights into huperzine A for the treatment of Alzheimer's disease
Zhang, H.-Y. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.128 · Cited by 87
Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice
Xu, Y.-H., Xu, K., Sun, Y., Liou, B., Quinn, B., Li, R.-H., Xue, L., Zhang, W., Setchell, K. D. R., Witte, D., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu105 · Cited by 89
Mitochondrial therapeutic interventions in Alzheimer’s disease
Van Giau, V., An, S. S. A., & Hulme, J. P. (2018) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2018.09.033 · Cited by 87
Ratan, Y., Rajput, A., Maleysm, S., Pareek, A., Jain, V., Pareek, A., Kaur, R., & Singh, G. (2023) · Biomedicines · doi:10.3390/biomedicines11051398 · Cited by 82
Somatostatin and Alzheimer's disease
Burgos‐Ramos, E., Hervás‐Aguilar, A., Aguado‐Llera, D., Puebla‐Jiménez, L., Hernández‐Pinto, A. M., Barrios, V., & Arilla, E. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.01.014 · Cited by 99
Dopaminergic midbrain neurons are the prime target for mitochondrial DNA deletions
Bender, A., Schwarzkopf, R.-M., McMillan, A., Krishnan, K. J., Rieder, G., Neumann, M., Elstner, M., Turnbull, D. M., & Klopstock, T. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0892-9 · Cited by 94
A Potential Alternative against Neurodegenerative Diseases: Phytodrugs
Pérez‐Hernández, J., Zaldívar-Machorro, V. J., David, V.-P., Vega‐Avila, E., & Chavarría, A. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8378613 · Cited by 95
He, J.-T., Zhao, X., Xu, L., & Mao, C.-Y. (2020) · Journal of Alzheimer’s Disease · doi:10.3233/jad-190764 · Cited by 84
Fang, D., Wang, Y., Zhang, Z., Du, H., Yan, S., Sun, Q., Zhong, C., Wu, L., Vangavaragu, J. R., Yan, S., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv241 · Cited by 85
Self-citationCyclophilin D deficiency rescues Aβ-impaired PKA/CREB signaling and alleviates synaptic degeneration
Du, H., Guo, L., Wu, X., Sosunov, A. A., McKhann, G. M., Chen, J. X., & Yan, S. S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.004 · Cited by 85
Self-citationIs the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease?
Reddy, P. H. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.09.003 · Cited by 87
Hu, H., & Li, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.07.071 · Cited by 94
Montemurro, C., Nomoto, H., Pei, L., Parekh, V. S., Vongbunyong, K. E., Vadrevu, S., Gurlo, T., Butler, A. E., Subramaniam, R., Ritou, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10444-1 · Cited by 103
Atamna, H., Frey, W. H., & Ko, N. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.05.003 · Cited by 89
Leuner, K., Stockburger, C., Denzer, I., Eckert, G. P., & Müller, W. E. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-394625-6.00007-6 · Cited by 94
Modes of Aβ toxicity in Alzheimer’s disease
Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 83
Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease
Harris, R. A., Tindale, L. C., & Cumming, R. C. (2014) · Biogerontology · doi:10.1007/s10522-014-9534-z · Cited by 90
Lahmy, V., Long, R., Morin, D., Villard, V., & Maurice, T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00463 · Cited by 84
Hass, M. R., Sato, C., Kopan, R., & Zhao, G. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.11.014 · Cited by 85
Yao, J., Taylor, M., Davey, F. D., Ren, Y., Aiton, J., Coote, P. J., Fang, F., Chen, J. X., Yan, S. D., & Gunn, F. J. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.03.013 · Cited by 95
Self-citationPascual-Ahuir, A., Manzanares-Estreder, S., & Proft, M. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9860841 · Cited by 81
Functions of amyloid precursor protein in metabolic diseases
Guo, Y., Wang, Q., Chen, S., & Xu, C. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154454 · Cited by 96
The Alzheimer’s Disease Mitochondrial Cascade Hypothesis: A Current Overview
Swerdlow, R. H. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221286 · Cited by 93
Oxidative Stress Level in Circulating Neutrophils Is Linked to Neurodegenerative Diseases
Vitte, J., Michel, B. F., Bongrand, P., & Gastaut, J. L. (2004) · Journal of Clinical Immunology · doi:10.1007/s10875-004-6243-4 · Cited by 94
Mitochondrial Function and Dysfunction: An Update
Davis, R. E., & Williams, M. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192104 · Cited by 96
Water Quality and Brain Function
Bondy, S. C., & Campbell, A. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15010002 · Cited by 87
Rhein, V., Giese, M., Baysang, G., Meier, F., Rao, S., Schulz, K. L., Hamburger, M., & Eckert, A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012359 · Cited by 81
Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides
Zhang, Q., Yang, G., Li, W., Fan, Z., Sun, A., Luo, J., & Ke, Z. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.005 · Cited by 84
Mitochondrial accumulation of APP and Aβ: significance for Alzheimer disease pathogenesis
Pavlov, P. F., Petersen, C. H., Glaser, E., & Ankarcrona, M. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00892.x · Cited by 82
Roles of 17β-hydroxysteroid dehydrogenase type 10 in neurodegenerative disorders
Yang, S.-Y., He, X.-Y., Isaacs, C., Dobkin, C., Miller, D., & Philipp, M. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.07.001 · Cited by 78
Lim, Y.-A., Grimm, A., Giese, M., Mensah-Nyagan, A. G., Villafranca, J. E., Ittner, L. M., Eckert, A., & Götz, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028887 · Cited by 80
Abnormal Mitochondrial Dynamics—A Novel Therapeutic Target for Alzheimer's Disease?
Su, B., Wang, X., Bonda, D., Perry, G., Smith, M., & Zhu, X. (2010) · Molecular Neurobiology · doi:10.1007/s12035-009-8095-7 · Cited by 82
Proteinopathies and OXPHOS dysfunction in neurodegenerative diseases
Kawamata, H., & Manfredi, G. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201709172 · Cited by 81
Henderson, V. W., & Brinton, R. D. (2010) · Progress in Brain Research · doi:10.1016/s0079-6123(10)82003-5 · Cited by 79
Inborn errors of isoleucine degradation: A review
Korman, S. H. (2006) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2006.07.010 · Cited by 82
Calingasan, N. Y., Chen, J., Kiaei, M., & Beal, M. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.01.012 · Cited by 83
Moreira, P. I. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-111127 · Cited by 82
Mitochondrial medicine for neurodegenerative diseases
Du, H., & Yan, S. S. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.01.004 · Cited by 81
Self-citationOverlapped Metabolic and Therapeutic Links between Alzheimer and Diabetes
Ahmad, W. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8352-z · Cited by 86
Ten Challenges of the Amyloid Hypothesis of Alzheimer’s Disease
Kepp, K. P. (2016) · Journal of Alzheimer's Disease · doi:10.3233/jad-160550 · Cited by 81
Cao, J., Zhong, M. B., Toro, C. A., Zhang, L., & Cai, D. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.03.016 · Cited by 79
Alzheimer's Disease and Amyloid: Culprit or Coincidence?
Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 91
Trimmer, P. A., & Borland, M. K. (2005) · Antioxidants & Redox Signaling · doi:10.1089/ars.2005.7.1101 · Cited by 79
Concentration‐dependent transitions govern the subcellular localization of islet amyloid polypeptide
Magzoub, M. M., & Miranker, A. D. (2011) · The FASEB Journal · doi:10.1096/fj.11-194613 · Cited by 87
Cell-specific Subcellular Localization of Soluble Epoxide Hydrolase in Human Tissues
EnayetAllah, A. E., French, R. A., Barber, M. R., & Grant, D. F. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5a6808.2005 · Cited by 80
APP transgenic mice: their use and limitations
Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease
Ouyang, Q., Meng, Y., Zhou, W., Tong, J., Cheng, Z., & Zhu, Q. (2021) · Journal of drug targeting · doi:10.1080/1061186x.2021.1927055 · Cited by 84
Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease
Torres, A. K., Jara, C., Park-Kang, H. S., Polanco, C. M., Tapia, D., Alarcón, F., de la Peña, A., Llanquinao, J., Vargas-Mardones, G., Indo, J. A., et al. (2021) · Journal of Alzheimer's Disease · doi:10.3233/jad-215139 · Cited by 75
Age‐related behaviors have distinct transcriptional profiles in Caenorhabditis elegans
Golden, T. R., Hubbard, A., Dando, C., Herren, M. A., & Melov, S. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00433.x · Cited by 88
Sirk, D., Zhu, Z., Wadia, J. S., Shulyakova, N., Phan, N., Fong, J., & Mills, L. R. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04907.x · Cited by 78
Oka, S., Leon, J., Sakumi, K., Ide, T., Kang, D., LaFerla, F. M., & Nakabeppu, Y. (2016) · Scientific Reports · doi:10.1038/srep37889 · Cited by 78
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction—the trigger for PANoptosis in neurons
Meng, X., Song, Q., Liu, Z., Liu, X., Wang, Y., & Liu, J. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1400544 · Cited by 88
Mitochondrial biology in Alzheimer’s disease pathogenesis
Galindo, M. F., Ikuta, I., Zhu, X., Casadesus, G., & Jordán, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06814.x · Cited by 79
How the Wnt signaling pathway protects from neurodegeneration: the mitochondrial scenario
Arrázola, M. S., Silva-Álvarez, C., & Inestrosa, N. C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00166 · Cited by 86
Liang, W. S., Dunckley, T. L., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K. M., Caselli, R. J., Kukull, W. A., McKeel, D. W., Morris, J. C., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.013 · Cited by 86
Unfolded protein stress in the endoplasmic reticulum and mitochondria: a role in neurodegeneration
Bernales, S., Soto, M. M., & McCullagh, E. (2012) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2012.00005 · Cited by 78
Surface plasmon resonance biosensors for detection of Alzheimer disease biomarker
Hegnerová, K., Bocková, M., Vaisocherová‐Lísalová, H., Krištofiková, Z., Říčný, J., Řípová, D., & Homola, J. (2008) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2008.09.006 · Cited by 82
Foldamer-Mediated Structural Rearrangement Attenuates Aβ Oligomerization and Cytotoxicity
Kumar, S., Henning‐Knechtel, A., Chehade, I., Magzoub, M. M., & Hamilton, A. D. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b08259 · Cited by 84
Journal of Parkinson’s disease & Alzheimer’s disease
(2014) · Journal of Parkinson’s disease and Alzheimer's disease · doi:10.13188/2376-922x.1000003 · Cited by 77
Algamal, M., Milojevic, J., Jafari, N., Zhang, W., & Melacini, G. (2013) · Biophysical Journal · doi:10.1016/j.bpj.2013.08.025 · Cited by 80
Heme binding to Amyloid-β peptide: Mechanistic role in Alzheimer's disease
Atamna, H. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-310 · Cited by 77
Intracellular and Extracellular Aβ, a Tale of Two Neuropathologies
Cuello, A. C. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2005.tb00101.x · Cited by 77
Amyloid β-induced ER stress is enhanced under mitochondrial dysfunction conditions
Costa, R. O., Ferreiro, E. B., Martins, I., Santana, I. J., Cardoso, S. M., Oliveira, C. R., & Pereira, C. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.011 · Cited by 87
Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011)
Probst, G., & Xu, Y.-Z. (2012) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2012.681302 · Cited by 76
The Ubiquitin System in Alzheimer’s Disease
Harris, L. D., Jasem, S., & Licchesi, J. D. F. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-38266-7_8 · Cited by 85
Qu, M., Jiang, Z., Liao, Y., Song, Z., & Nan, X. (2016) · Neurochemical Research · doi:10.1007/s11064-016-1837-9 · Cited by 80
Oral, Ö., Akkoç, Y., Bayraktar, O., & Gözüaçık, D. (2016) · PubMed · doi:10.14670/hh-11-714 · Cited by 90
The Bewildering Effect of AMPK Activators in Alzheimer’s Disease: Review of the Current Evidence
Assefa, B. T., Tafere, G. G., Wondafrash, D. Z., & Gidey, M. T. (2020) · BioMed Research International · doi:10.1155/2020/9895121 · Cited by 74
Han, Y., Wang, N., Kang, J., & Fang, Y. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00587-2 · Cited by 77
Self-citationYu, W., Jin, H., & Huang, Y. (2021) · Clinical Science · doi:10.1042/cs20200844 · Cited by 81
Valasani, K. R., Hu, G., Chaney, M. O., & Yan, S. S. (2012) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12068 · Cited by 82
Self-citationWang, D., Li, S., Zhu, X., Wang, Y., Wu, W., & Zhang, X. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1013-4 · Cited by 76
Šišková, Z., Mahad, D., Pudney, C., Campbell, G. R., Cadogan, M., O'Connor, V. M., Asuni, A. A., & Perry, V. H. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091037 · Cited by 81
Zhang, Q., Song, Q., Yu, R., Wang, A., Jiang, G., Huang, Y., Chen, J., Xu, J., Wang, D., Chen, H., et al. (2023) · Advanced Science · doi:10.1002/advs.202204596 · Cited by 93
Rezaee, D., Saadatpour, F., Akbari, N., Zoghi, A., Najafi, S., Beyranvand, P., Rarani, F. Z., Rashidi, M. A., Bagheri‐Mohammadi, S., & Bakhtiari, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102090 · Cited by 79
Ye, J., Meng, X., Yan, C., & Wang, C. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0063-0 · Cited by 85
Drago, D., Cavaliere, A., Mascetra, N., Ciavardelli, D., Di Ilio, C., Zatta, P., & Sensi, S. L. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0761 · Cited by 75
Non-cholinergic Effects of Huperzine A: Beyond Inhibition of Acetylcholinesterase
Zhang, H., Yan, H., & Tang, X. C. (2007) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-007-9163-z · Cited by 78
Toxic Role of K+Channel Oxidation in Mammalian Brain
Cotella, D., Hernández-Enríquez, B., Wu, X., Li, R., Pan, Z., Leveille, J., Link, C. D., Oddo, S., & Sesti, F. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6153-11.2012 · Cited by 80
Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration
Ramsay, R. R., Májeková, M., Medina, M., & Valoti, M. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00375 · Cited by 80
Metadata
- Authors
- Lustbader, J. W., Cirilli, M., Lin, C., Xu, H. W., Takuma, K., Wang, N., Caspersen, C., Chen, X., Pollak, S., Chaney, M., Trinchese, F., Liu, S., Gunn-Moore, F., Lue, L.-F., Walker, D. G., Kuppusamy, P., Zewier, Z. L., Arancio, O., Stern, D., Yan, S. S., & Wu, H.
- Affiliations
- Harbin Medical University (CN)
- Center for Reproductive Sciences and Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, New York, NY 10032, USA.
- Corresponding author
- Lustbader, Joyce W.
- Cirilli, Maurizio
- Lin, Chang
- Takuma, Kazuhiro
- Wang, Ning
- Yan, Shirley ShiDu
- Wu, Hao
- ORCID
- Venue
- Science
- Published
- 2004-04-16
- Volume
- 304
- Issue
- 5669
- Pages
- 448-452
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2163757074
- Cited by
- 1,303
- References
- 22
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 43 · 2023: 51 · 2022: 53 · 2021: 64 · 2020: 73 · 2019: 63 · 2018: 61 · 2017: 55 · 2016: 71 · 2015: 42 · 2014: 62 · 2013: 59 · 2012: 76
- FWCI
- 38.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-17490, AG 16736, K07AG000959, P50AG008702, P01AG017490, R01AG016736)
- National Institute of Neurological Disorders and Stroke (NS 42855, R01NS042855)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, alcohol dehydrogenase, mitochondrial toxicity, mitochondrial dysfunction, NAD+ binding, protein-protein interaction, oxidative stress, neuronal apoptosis, free radicals, memory impairment, therapeutic target
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Amino Acid Sequence, Animals, Binding Sites, Brain, Brain Chemistry, Carrier Proteins, Cells, Cultured, Cerebral Cortex, Crystallization, Hippocampus, Humans, Learning, Memory, Mice, Transgenic, Mitochondria, Models, Molecular, Molecular Sequence Data, Mutation, NAD, Neurons, Protein Binding, Protein Conformation, 3-Hydroxyacyl CoA Dehydrogenases, Amyloid beta-Peptides, Microscopy, Immunoelectron, Reactive Oxygen Species, Microscopy, Confocal, Mice, DNA Fragmentation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.